The Comptroller General of Medicines of India (DCGI) has granted permission to the Pune Serum Institute of India (SII) to resume its phase two and three clinical trials of the Oxford Covid-19 candidate vaccine in the country. DCGI VG Somani, in a letter to SII, has said that the institute’s …
Read More »
Oxford University resumed testing the coronavirus vaccine in the United States on Saturday following confirmation by the Medicines Health Regulatory Authority (MHRA). The advanced COVID-19 vaccine trial developed by the University of Oxford and Astrazeneca was suspended this week after illness in a study subject in Britain. Here is the …
Read More »
After Astrazeneca resumed testing of the Oxford University coronavirus vaccine in the UK, the Serum Institute of India said on Saturday it will restart the trial in the country once allowed by the main drug regulator. Commenting on the resumption of the trial, Adar Poonawalla, executive director of the Serum …
Read More »
Written by Prabha Raghavan | New Delhi | Updated: September 11, 2020 7:29:25 am Covid-19 testing in New Delhi. IBS Sponsors Mid- and Late-Stage Human Clinical Trials for Candidate Vaccine in India Serum Institute of India has decided to stop the ongoing clinical trials in India of the Covid-19 candidate …
Read More »
LONDON: AstraZeneca CEO Pascal Soriot on Wednesday expressed his hopes that a vaccine against the novel coronavirus developed by the pharmaceutical company will be ready by the end of 2020 or early 2021, despite having to pause clinical trials. Earlier this week, the Swedish-British company froze the trials after discovering …
Read More »
LONDON: AstraZeneca CEO Pascal Soriot on Wednesday expressed his hopes that a vaccine against the novel coronavirus developed by the pharmaceutical company will be ready by the end of 2020 or early 2021, despite having to pause clinical trials. Earlier this week, the Swedish-British company froze the trials after discovering …
Read More »
The Serum Institute of India said on Thursday it was halting the University of Oxford-Astrazeneca’s COVID-19 vaccine trial in India until the British-Swedish drugmaker restarts the trial. The move came a day after the Pune-based vaccine maker received a notice of demonstration cause from the Drugs General Inspector of India …
Read More »
The Serum Institute of India (SII) said on Wednesday that the drugmaker will follow instructions from the central drug regulator on suspending the Oxford-AstraZeneca COVID-19 vaccine trial in India. The Controller General of Drugs of India (DCGI) issued a notice of demonstrative cause to the Serum Institute of India on …
Read More »
Written by Abhishek De | New Delhi | Updated: September 7, 2020 9:27:45 pm According to the World Health Organization, about 175 vaccine candidates are in preclinical or clinical trials today. While Russia and China may have stolen a march in the race to develop a Covid-19 vaccine, grant regulatory …
Read More »
The whole world is waiting with great anticipation for a ‘safe and effective’ vaccine against the new coronavirus. Currently, three candidate vaccines are in different stages of testing in India. Two homegrown candidate vaccines, Covaxin from Bharat Biotech and ZyCoV-D from Zydus Cadila have already started the phase II clinical …
Read More »